M. Broscious

发表

Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting

B. Feinberg, J. Kish, S. Mougalian, 2018, Cancer medicine.